XYLOCAIN GEL 2%, 30 g

Instructions for use for XYLOCAIN GEL 2%, 30 g

Field of use

• Medicines for the superficial anesthesia of the mucous membranes (local anesthetic).
• It is used for the local anesthesia of mucous membranes and as lubricants, e.g. B. the
  • Introduction of a ventilation pipe,
  • internal examination with an endoscope,
  • Introduction of a catheter.

Active ingredients / ingredients / ingredients

21.33 mg lidocaine hydrochloride 1 water
17.31 mg lidocaine
20 mg lidocaine hydrochloride
Hypromellic auxiliary substance (+)
Sodium hydroxide auxiliary substance (+)
Salic acid, concentrated auxiliary material (+)
Water, cleaned auxiliary material (+)
0.7 mg methyl 4-hydroxybenzoat auxiliary substance (+)
0.3 mg propyl 4-hydroxybenzoat auxiliary substance (+)

Contradictions

• The medicine must not be applied if they are hypersensitive to (allergic) opposite
  • the active ingredient lidocaine,
  • certain other means of interception of pain (local anesthetics from the amid and ester type), or or
  • are one of the other components of the drug.
• You must also not use the medicine if you
  • significant disorders of the heart's stimulus system,
  • Hard -performance weakness, which cannot be compensated for by increased activity of the heart muscle (decompensated heart failure) or
  • suffer from a shock due to reduced cardiac activity or reduced circulating blood amount (cardiogenic and hypovolemic shock).

dosage

• Always apply the medicine exactly according to the instruction. Please ask your doctor or pharmacist if you are not quite sure.
• The medicine causes a rapid and profound local anesthesia of long duration on mucous membranes (approx. 20 to 30 minutes). In general, local anesthesia occurs quickly (within 5 minutes, depending on the location of the application).
• The doctor must be dosed individually by the doctor.
• In weakened or older patients, patients with acute or in patients with patients with sepsis, dosage of age, weight and the physical general condition should be adjusted.
• The following dosage recommendations apply:
  • Implementation of the local anesthesia of the urethra
    • a) in men:
      • The urethral end and the glans are cleaned and disinfected. The conical introduction tube, which is added to each pack, is screwed onto the tube thread and inserted into the urethral mouth. By turning the tube key, the drug is carefully inserted into the urethra (urethra) until the patient gives a feeling of tension (about 8 g). So that no drug can flow back from the urethra, a penis clamp is created a little above the Corona Glandis and after 3 to 4 minutes again about 8 g of the preparation is brought into the urethra in the same way. The local anesthesia that is used immediately after the gel is introduced is sufficient to carry out minor interventions (e.g. catheterization for bladder emptying). This preparation is an excellent lubricant when using catheters and for bladder mirroring.
    • b) for women:
      • After the previous cleaning of the urethral mouth, about 5 g of the drug are placed in small portions into the urethra (instilled). A few minutes should be serviced before the urological intervention has been carried out so that sufficient local anesthesia is achieved.
    • Application in anesthesiology
      • Spread approximately 5 g over the lower third of the tube. In order to avoid drying out, the preparation is only applied to the instrument immediately before application. One should particularly make sure that the gel does not get into the lumen of the tube.
    • Maximum dose
      • The maximum dose is 16 g for adults with Normalem body weight (70 kg). For children and patients in weakened general condition, the maximum dose in MG Lidocainhydrochloride/KG body weight must be calculated (2.9 mg lidocainhydrochloride/kg body weight).

• The treating doctor determines the duration of the treatment.
• Please speak to your doctor if you have the impression that the effect is too strong or too weak.

• If you have used a larger amount than you should,
  • the following symptoms can occur:
    • Excitation, unrest, dizziness, hearing and visual disturbances, tingling on the mouth (perioral), washed out language, nausea, vomiting, tremors and muscle twitches. These so -called excitatory symptoms are a sign of an impending seizure.
    • Symptoms relating to the cardiovascular system (cardiovascular symptoms) can be:
      • Rhythm disorders, too fast heartbeat, too high blood pressure and reddening of the skin.
  • As the overdose progresses, there is a suppression of functions of the central nervous system and the heart (depression of central and cardiac functions) with a coma, breathing and circulatory arrest. The first symptom is often the low blood pressure.
  • If symptoms occur as described above, the application must be interrupted immediately. Contact your doctor immediately. He will initiate the emergency measures according to the disease signs.

• If you have any further questions about the application of the drug, ask your doctor or pharmacist.

Taking

• To apply the mucous membrane.
• Notice
  • The preparation was sterilized at the time of production. Please note that the tube content becomes unsteril after a one -time application.

Patient information

• Special care in the application is required if you
  • Circulatory disorders of the coronary arteries or weakness in the heart,
  • an advanced liver disease,
  • a reduced kidney function suffer
  • or are generally in poor health.
  • If you suffer from a disorder of the blood -forming system (porphyria), you may only apply the medicine with medical monitoring. The preparation may also be able to trigger porphyria. Please ask your doctor.
  • Special caution is also required if you have certain changes in the pelvic floor (Bulboocavernese connection). With such a change, it is possible that the active ingredient gets into the bloodstream. This may cause serious side effects. Therefore, please ask your doctor before an application. He will weigh the risk of using this drug against the possible benefit.
  • This also applies if you apply the preparation to wound areas, since there is a risk that larger amounts of the active ingredient will be absorbed by the body. Therefore, only use the medicine after consultation with your doctor.
  • Do not apply the drug in large quantities and not more often than prescribed by the doctor, since severe side effects can occur due to the enrichment of the active ingredient in the blood. Emergency medical treatment may then be necessary.
  • If you use the medicine in the mouth or throat, swallowing can be difficult. Then there is a risk that they swallow. They could also bite into the tongue or cheek if these areas are stunned.
  • a) Children
    • In children, the dosage must be adapted to the body weight. Always ask your doctor about this.
  • b) older people
    • The dosage must be adjusted for them. Please ask your doctor.

• Wateriness and operating machines
  • Your doctor will tell you whether you can take part in road traffic or operate machines after using the drug.

Pregnancy

• Lidocaine should be in pregnancy, at Ican only be applied if your treating doctor considers it absolutely necessary because no controlled studies have been carried out on pregnant women.
• So far, there are no evidence of innate malformations after using lidocaine during pregnancy.
• It is known that lidocaine transfers into the placenta into the body after injection. However, there are no studies on a transfer to the placenta after applying the skin or mucous membrane.
• After injection into the body, lidocaine merges into breast milk in small quantities. Investigations into the transition to breast milk after applying the skin and mucous membrane are not available, but a risk to the baby is unlikely.

Hints